Updated 10/17/2020
Biosafety Officer: Ryan Bartlett, [email protected], (406) 994-6733
MSU Office of Research Compliance

The IBC reviews and approves many laboratory activities which may include research, teaching, and diagnostic activities.

All activities (e.g. research, teaching, diagnostic) conducted/performed at MSU, or funded by a grant awarded to an MSU PI which conform to the descriptions listed below must submit an IBC protocol.

The IBC defines potentially biohazardous materials to include all infectious organisms (bacteria, chlamydia, parasites, fungi, prions, rickettsia, and viruses), toxins, and recombinant/synthetic nucleic acid materials which can cause disease or illness in humans, animals, or plants, or cause significant environmental or agricultural impact. Materials that may harbor infectious organisms, such as human or primate tissues, fluids, cells, cell cultures, soils, and infected plants are also considered biohazardous.

Projects involving materials included in any of these categories must secure IBC approval prior to initiation:

  • Recombinant or synthetic nucleic acid molecules (e.g. rDNA).
  • Genetically modified organisms (GMOs) including, but not limited to:
    • Animals, plants, invertebrates, and/or other organisms created by MSU employees or in/on MSU property
    • Transgenic field trials, any regulated genetically modified organisms to be introduced into the environment.
    • Field testing of plants engineered to produce pharmaceutical and industrial compounds.
  • Pathogens/infectious agents and pests (RG2/BSL2 or higher), human and animal pathogens, non-indigenous plant pathogens as well as those plant and animal pests regulated by the USDA-APHIS.
  • Select/Biological Agents and Toxins (CDC and USDA). Please note that possession, use, or transfer of Select Agents and Toxins entails additional requirements –contact the ORC for additional information.
  • Unfixed human and non-human primate cells (including cell lines), tissue, blood and potentially infectious body fluids.
  • Work with animals or vectors known or suspected to be reservoirs of RG2 or RG3 infectious agents when such work increases potential exposure risks to personnel or other animals.
  • Oncogenic viruses used in conjunction with animals.